73362-202-01 : NDC 2026 Code

73362-202-01 : Navepegritide ( Yuviwel )

Additionally :

You can get information about “73362-202-01” NDC code in 73362-202-01 in HTML format

HTML | 73362-202-01 in TXT (Plain Text) format

TXT | 73362-202-01 in PDF (Portable Document Format)

PDF | 73362-202-01 in XML format

XML formats.

NDC Code : 73362-202-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "73362-202-01",
    "PackageDescription": "4 BOX in 1 CARTON (73362-202-01)  / 1 KIT in 1 BOX (73362-202-02)  *  1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (73362-206-01)  *  1 SOLUTION in 1 SYRINGE, GLASS (73362-801-01) ",
    "NDC11Code": "73362-0202-01",
    "ProductNDC": "73362-202",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Yuviwel",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Navepegritide",
    "DosageFormName": "KIT",
    "RouteName": null,
    "StartMarketingDate": "20260227",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA219164",
    "LabelerName": "Ascendis Pharma Endocrinology, Inc.",
    "SubstanceName": null,
    "StrengthNumber": null,
    "StrengthUnit": null,
    "Pharm_Classes": null,
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-03-27",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260227",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}